Treating Reproductive-Aged Women With Glucagon-Like Peptide-1 Receptor Agonists: What Are the Clinical Considerations?

被引：0
作者：
Sharma, Garima [1 ]
机构：
[1] Inova Hlth Syst, Inova Schar Heart & Vasc, 8081 Innovat Pk Dr,7th Fl,700, Fairfax, VA 22031 USA
来源：
CIRCULATION | 2024年 / 150卷 / 19期
关键词：
cardiovascular-kidney-metabolic; GLP-RA; obesity; pregnancy;
D O I：
10.1161/CIRCULATIONAHA.124.070766
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1487 / 1489
页数：3
相关论文
共 50 条
[31]   Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer? [J].
Resnick, Ortal ;
Bril, Fernando ;
Beauchamp, Giovanna .
FRONTIERS IN ENDOCRINOLOGY, 2025, 15
[32]   Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome [J].
Tzotzas, Themistoklis ;
Karras, Spyridon N. ;
Katsiki, Niki .
CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (03) :218-229
[33]   Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases [J].
Vilarrasa, E. ;
Nicolau, J. ;
de la Cueva, P. ;
Goday, A. ;
Gallardo, F. ;
Martorell, A. ;
Carrascosa, J. M. .
ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (01) :56-65
[34]   Pulse of Progress: A Systematic Review of Glucagon-Like Peptide-1 Receptor Agonists in Cardiovascular Health [J].
Sabina, Michael ;
Alsamman, M. Mrhaf .
CARDIOLOGY RESEARCH, 2024, 15 (01) :1-11
[35]   An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning [J].
Rameshrad, Maryam ;
Razavi, Bibi Marjan ;
Lalau, Jean-Daniel ;
De Broe, Marc E. ;
Hosseinzadeh, Hossein .
IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 23 (05) :556-568
[36]   Tolerability and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Inflammatory Bowel Disease [J].
Clarke, Lindsay ;
Passam, Ravi Teja ;
Falahee, Bryn ;
Jirapinyo, Pichamol ;
Allegretti, Jessica R. ;
Kelly, Colleen R. .
DIGESTIVE DISEASES AND SCIENCES, 2025, 70 (07) :2426-2432
[37]   Glucagon-Like Peptide-1 Receptor Agonists in Patients With Durable Left Ventricular Assist Devices [J].
Elad, Boaz ;
Lee, Changhee ;
Rahman, Afsana ;
Rzechorzek, Wojciech ;
DeFilippis, Ersilia M. ;
Lotan, Dor ;
Moeller, Cathrine M. ;
Valledor, Andrea Fernandez ;
Rahman, Salwa ;
Baranowska, Julia ;
Clerkin, Kevin ;
Fried, Justin ;
Yunis, Adil ;
Yuzefpolskaya, Melana ;
Colombo, Paolo C. ;
Kaku, Yuji ;
Naka, Yoshifumi ;
Takeda, Koji ;
Raikhelkar, Jayant ;
Sayer, Gabriel T. ;
Uriel, Nir .
ARTIFICIAL ORGANS, 2025, 49 (05) :864-871
[38]   Glucagon-like peptide-1 receptor agonists in the era of COVID-19: Friend or foe? [J].
Belancic, Andrej ;
Kresovic, Andrea ;
Troskot Dijan, Marija .
CLINICAL OBESITY, 2021, 11 (02)
[39]   Glucagon-like peptide-1 receptor agonists: the key to healthy weight loss maintenance? COMMENT [J].
Lehmann, Eva Winning ;
Torekov, Signe Sorensen .
CARDIOVASCULAR RESEARCH, 2021, 117 (10) :E120-E122
[40]   Promising Real-World Data on Glucagon-Like Peptide-1 Receptor Agonists in Dialysis [J].
Shin, Jung-Im ;
Chang, Alexander R. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025,
12345